Emerging Stocks Down Under 30 November 2021: Nearmap, Clarity Pharmaceuticals, Pacific Edge

Nearmap: Medium term upside in a downtrend

In today’s edition of Emerging Stocks Down Under, aerial imaging company Nearmap has been on a longer term downtrend. But we believe there may be upside to $1.90-2.00 within that downtrend in the near to medium term.

 

Also in today’s edition, radiopharmaceutical company Clarity Pharmaceuticals (ASX: CU6) and cancer diagnostics company Pacific Edge (ASX: PEP).

 

Click here to read the previous edition of Emerging Stocks Down Under published 23 November 2021

For in-depth research reports or to keep up-to-date on the latest Stocks Down Under news see our parent company, Pitt Street Research, or follow us on Facebook and Twitter.